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Mutations in a Novel Isoform of TRIOBP That Encodes a Filamentous-
Actin Binding Protein Are Responsible for DFNB28 Recessive
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In a large consanguineous Palestinian kindred, we previously mapped DFNB28—a locus associated with recessively
inherited, prelingual, profound sensorineural hearing impairment—to chromosome 22q13.1. We report here that
mutations in a novel 218-kDa isoform of TRIOBP (TRIO and ﬁlamentous actin [F-actin] binding protein) are
associated with DFNB28 hearing loss in a total of nine Palestinian families. Two nonsense mutations (R347X and
Q581X) truncate the protein, and a potentially deleterious missense mutation (G1019R) occurs in a conserved
motif in a putative SH3-binding domain. In seven families, 27 deaf individuals are homozygous for one of the
nonsense mutations; in two other families, 3 deaf individuals are compound heterozygous for the two nonsense
mutations or for Q581X and G1019R. The novel long isoform of TRIOBP has a restricted expression proﬁle,
including cochlea, retina, and fetal brain, whereas the original short isoform is widely expressed. Antibodies to
TRIOBP reveal expression in sensory cells of the inner ear and colocalization with F-actin along the length of the
stereocilia.
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Approximately 1 in 1,000 children in the United States
are born with hearing loss, and ∼60% of these cases are
due to genetic factors (Marazita et al. 1993). The genetic
causes of hearing loss are highly heterogeneous: 89 loci
for hereditary hearing loss have been mapped, and 45
of the corresponding genes have been cloned (Hereditary
Hearing Loss Homepage). Many of these genes were ﬁrst
identiﬁed in extended consanguineous kindreds. In par-
ticular, studies in the Palestinian population, which has
a long historical tradition of endogamous marriage, pro-
vided the ﬁrst clues to the identiﬁcation of TMPRSS3
(Bonne-Tamir et al. 1996; Scott et al. 2001), stereocilin
(Campbell et al. 1997; Verpy et al. 2001), otoancorin
(Zwaenepoel et al. 2002),whirlin (Mustapha et al. 2002;
Mburu et al. 2003), and DFNB33 (Medlej-Hashim et
al. 2002). In addition, pendrin (Baldwin et al. 1995) and
DFNB17 (Greinwald et al. 1998) were ﬁrst mapped in
Palestinian Druze families.
To identify novel genes for hereditary hearing loss, we
ascertained children with prelingual hearing loss from
Palestinian schools for the deaf. Thus far, 156 families
have been enrolled in the study. One of these, family K,
is an Orthodox Christian family that traces its ancestry
since the mid-eighteenth century to the area of Bethle-
hem and Beit Sahour. Pure-tone audiometry and vision
tests were performed at audiology centers in the Pales-
tinian Authority. Hearing loss in family K was sensori-
neural, bilateral, symmetrical, and profound; the mode
of inheritance appeared to be recessive. No signs of
mixed hearing loss were noted, and vision was normal.
Blood samples were drawn from participating individ-
uals after informed consent was obtained in accordance
with the guidelines of the BethlehemUniversity Research
Committee, the Tel Aviv University Helsinki Commit-
tee, and the University of Washington Human Subjects
Division.
To map the gene for hearing loss in family K, we
performed genomewide linkage analysis with DNA from
18 informative relatives, using 379 markers from ABI
PRISM Linkage Mapping Set 2 (Applied Biosystems).
Allele sizes were determined using ABI GENESCAN ver-
sion 2.02 software with manual review. Software de-
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Table 1
RT-PCR Primers for TRIOBP
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 2
Exons of Mouse TRIOBP Isoforms Aligned to UCSC
Genome Browser March 2005 Assembly, Chromosome 15
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
veloped in our laboratories displays genotypes for ped-
igrees and collects data from automated genome scans
for linkage analysis by FASTLINK version 3.0 (Lath-
rop et al. 1984) and LINKAGE version 5.1 (Cotting-
ham et al. 1993). The genomewide scan yielded a max-
imum LOD score of 4.19 for linkage of hereditary hear-
ing impairment to marker D22S423 on chromosome
22q13.1. Fine mapping with additional microsatellite
markers deﬁned linkage to inherited hearing loss in fam-
ily K at the 6.3-Mb region bounded by D22S1045 and
D22S282 (ﬁg. 1A). We named this locus “DFNB28”
(Walsh et al. 2000).
To further constrain the region of linkage, we mapped
markers from the D22S1045–D22S282 interval in other
Palestinian kindreds with prelingual, profound hearing
loss. In three apparently unrelated families—AX, AY,
and BD—linkage of hearing loss was consistent with
DFNB28 (ﬁg. 1A). Families K, AX, AY, and BD were
not aware of any biological relationship to one another
but were from the same small geographic area and were
part of the same Orthodox Christian community, which
suggests an ancestral relationship. We tested homozy-
gosity in the D22S1045–D22S282 interval among deaf
individuals in these four families, using 76 informative
SNPs and microsatellite markers (ﬁg. 1B). Regions of
939 kb, 316 kb, and 259 kb were homozygous either
by descent or by state in all individuals with hearing
loss. These three regions of homozygosity harbored 34
known or hypothetical genes (UCSC Genome Browser
May 2004 assembly). We sequenced all known exons,
ﬂanking splice junctions, and the 5′-UTR and 3′-UTR
regions of these genes and found no variants likely to
be pathogenic. (A list of variant sites is available on
request.)
The homozygous region of 939 kb (ﬁg. 1B) harbored
the gene encoding TRIOBP (also known as “TARA” or
“HRIHFB2122”), a ﬁlamentous actin (F-actin) binding
protein that associates with the TRIO guanine nucleo-
tide exchange factor and regulates actin cytoskeleton
organization (Seipel et al. 2001). TRIOBP was an ex-
cellent gene candidate for DFNB28 hearing loss, because
of both its position and its function. However, the
known exons of TRIOBP yielded no likely pathogenic
mutations in families K, AX, AY, and BD. Therefore, we
used information from databases to explore whether ad-
ditional, previously undetected alternate transcripts of
TRIOBP might be hidden in incompletely annotated ge-
nomic regions.
The UCSC Human Genome Browser May 2004 as-
sembly includes as known genes two isoforms of
TRIOBP that share the same translation start site at
22:36466921 and the surrounding CpG island. In ad-
dition, two transcripts listed in GenBank, AB051449
from brain and AK096634 from fetal brain, share some
exons with TRIOBP and include additional exons that
extend the locus 50 kb upstream of the known TRIOBP
sequence. However, AB051449 and AK096634 differ
from one another and from both annotated TRIOBP
sequences. Neither AB051449 nor AK096634 includes
a likely translation start site or maps near a CpG island.
The closest CpG island to the uncharacterized transcripts
lies at the 5′ end of another uncharacterized transcript,
AL160132, which suggests that the complete TRIOBP
locus might encompass 86 kb of genomic sequence
rather than 28 kb, the size of original TRIOBP. In con-
trast to the human sequence, mouse sequence from the
UCSC Genome Browser March 2005 assembly did not
include any transcripts suggesting longer isoforms of
TRIOBP. However, comparison of sequence on human
chromosome 22 and syntenic mouse chromosome 15
indicated highly conserved sequence at multiple sites in
the hypothetical 86-kb TRIOBP locus. We hypothesized
that these conserved regions might include exons cor-
responding to long isoforms of TRIOBP in both human
and mouse and that some of these isoforms might be
expressed in cochlea.
To identify exons that were part of longer TRIOBP
transcripts, we undertook several experiments. We ﬁrst
generated cDNA speciﬁc to TRIOBP by reverse tran-
scription of total RNA from mouse cochlea, mouse
brain, and human fetal brain, using primers matching
the 3′ UTR of human and mouse original TRIOBP (table
1). We then used sequences of AB051449, AK096634,
and AL160132 and orthologous sequence in mouse to
design primer pairs for ampliﬁcation of mouse and hu-
man TRIOBP-speciﬁc cDNAs (table 1). We sequenced
the products, aligned traces to mouse and human ge-
nomes by BLAT, and annotated the exons (ﬁg. 2A and
2B). Interestingly, experimentally determined sequence
from human fetal brain differed in exon structure from
all of AB051449, AK096634, and AL160132, suggest-
ing multiple alternative transcripts of the long isoform.
From mouse cochlea, the ORF of the longest isoform
of TRIOBP from cochlea comprises 5,907 bp in 21 cod-
ing exons, encoding a predicted 219-kDa protein of
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Table 3
Exons of Human TRIOBP Isoforms Aligned to UCSC
Genome Browser May 2004 Assembly, Chromosome 22
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 1 Palestinian families with hereditary hearing loss linked to 6.3 Mb on chromosome 22q13 (DFNB28). A, Families K, AX, AY,
and BD. In these families, hearing loss is linked to two haplotypes, shown in yellow and green. The order of markers was determined from
the genomic sequence of chromosome 22 (UCSC Genome Browser May 2004 assembly). B, Homozygosity mapping based on 76 SNPs and
microsatellite markers. Genotypes in red are shared by the yellow and green haplotypes. Black vertical lines indicate regions of 939 kb, 316
kb, and 259 kb that were identical either by descent or by state in all affected individuals. The position of TRIOBP in the 939-kb homozygous
region is indicated. C, Families A17, AK, X7, and AZ. In these families, hearing loss was also linked to markers at DFNB28.
1,969 aa (GenBank accession number DQ278602) (ﬁg.
2A and table 2). From human fetal brain, the ORF of
the longest isoform of TRIOBP comprises 6,801 bp in
19 coding exons, encoding a predicted 250-kDa protein
of 2,267 aa (GenBank accession number DQ278603)
(ﬁg. 2A and table 3). Remarkably, the human fetal brain
transcript includes eight exons in the 5′ UTR (table 3),
of which six (exons 1–6) are an ORF potentially en-
coding 213 aa, which raises the possibility of still other
translation start sites associated with alternative splicing.
Reading frames of the long and short isoforms of
TRIOBP are the same. Independent transcription and
translation of the short isoform are maintained because
both mouse and human long isoforms skip exon 1 of
the short isoform, which contains an alternate 5′ UTR
and 2 aa (ﬁg. 2A). Predicted human and mouse protein
sequences speciﬁc to the long isoform of TRIOBP (hu-
man aa 31–1689 and mouse aa 34–1390) are 56% iden-
tical; human and mouse protein sequences of original
TRIOBP (human aa 1690–2267 and mouse aa 1391–
1969) are 88% identical. In the large central exon of
the long isoform (ﬁg. 2A), the human transcript includes
more replicates of a repeated motif than does the mouse
transcript, leading to a predicted protein in human com-
prising 298 more amino acid residues than the predicted
protein in mouse.
To evaluate expression of the short and long isoforms
of TRIOBP, we performed RT-PCR in 11 human tissues
(ﬁg. 2C). Primer pairs were speciﬁc to each isoform (ta-
ble 1); in particular, the forward primer for the short
isoform was located in original TRIOBP exon 1, which
is skipped in the long isoform. The short transcript was
highly expressed in all tissues tested. The long transcript
was expressed in fetal brain, retina, and cochlea but was
not detectable in the other tissues (ﬁg. 2C).
Expression of the long TRIOBP transcript, whichwas
restricted but included cochlea, suggested that it might
be a candidate gene for DFNB28 hearing loss. Using
genomic DNA of deaf individuals and obligate carriers
from families K, AX, AY, and BD (ﬁg. 1A), we sequenced
each newly identiﬁed exon of the long TRIOBP iso-
form.We identiﬁed a previously unreported substitution,
1039CrT, in human coding exon 5 that was homozy-
gous in all deaf relatives in families K, AX, AY, and BD
and heterozygous in obligate carriers (ﬁg. 3A). Predicted
translation of human cochlear and fetal brain transcripts
indicated that 1039CrT would yield nonsense mutation
R347X. The orthologous mouse substitution would also
create a stop codon.
In parallel, we tested other Palestinian families for
linkage of hearing loss to the DFNB28 locus. In three
families—A17, AK, and AZ (ﬁg. 1C)—marker genotypes
were consistent with linkage to the DFNB28 region. No
one in these three families carried the R347X mutation.
However, sequence of the newly discovered exons in deaf
individuals from these families revealed another non-
sense mutation, 1741CrT (Q581X), in the same exon
of TRIOBP (ﬁg. 3B). All 12 deaf individuals in families
A17, AK, and AZ were homozygous for Q581X. Both
R347X and Q581X lead to truncation of the long
TRIOBP isoform but are predicted to have no effect on
the short TRIOBP isoform, since the latter is transcribed
from an alternate ﬁrst exon.
We screened R347X and Q581X in all deaf probands
of the 156 families in our study. As mentioned above,
families K, AX, AY, and BD, which harbor R347X, are
Orthodox Christian. Families A17, AK, and AZ, which
harbor Q581X, are Muslim. Because the Palestinian
Orthodox Christian and Muslim communities are each
highly endogamous, it is not surprising that they harbor
different mutations, though in the same gene. It was
interesting, therefore, to identify family X7, in which the
two deaf children were both compound heterozygous
for R347X and Q581X.
Among the probands genotyped for the two nonsense
mutations was a child of age 3 years with profound
hearing loss who was heterozygous for R347X and did
not carry the Q581X mutation. The child inherited
R347X from her hearing father. We fully sequenced the
long isoform of TRIOBP in this child and found her to
be heterozygous for another novel mutation, 3055GrA
(G1019R), which was inherited from her hearingmother
(ﬁg. 3C). G1019R is a nonconservative amino acid sub-
stitution in a 521-aa proline-rich region (ﬁg. 4). Analysis
with bioinformatics tools suggests that this region may
function as an SH3-binding domain (Ren et al. 1993;
ﬁg. 5); three PXXP-containing SH3-binding sites are pre-
Figure 2 Determination of the genomic structure of isoforms of TRIOBP. A, Mouse and human TRIOBP isoforms ampliﬁed from cDNA
derived from mouse cochlea and human fetal brain. RT-PCR primer pairs 1F-2R and 2F-1R were used to determine the mouse long isoform
of TRIOBP. RT-PCR primers H1-H5 (table 1; not shown in this ﬁg.) were used to determine the human long isoform of TRIOBP. RT-PCR
primers 6F-6R and 7F-7R were used to test expression in multiple human tissues. B, Mouse cochlear and brain cDNA ampliﬁed by RT-PCR.
Products were electrophoresed on agarose gels alongside a molecular-weight size marker. C, Expression of short and long transcripts of TRIOBP
in human tissues. Human adult cochlear total RNA was obtained from Phylogeny and ﬁbroblast RNA was a gift from Peter Byers (University
of Washington). All other RNAs were purchased from Clontech. Total RNA (5 mg) was reverse transcribed with a primer located in the shared
3′ UTR of both isoforms (table 1). cDNA was ampliﬁed for 30 cycles with primers 6F-6R and 7F-7R, speciﬁc to each isoform (table 1), and
products were electrophoresed on an agarose gel alongside a molecular-weight size marker. The original TRIOBP isoform is widely expressed
in all tissues tested. The novel long isoform is expressed only in fetal brain, cochlea, and retina. Ex p exon.
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Figure 3 Sequences of mutations in the long isoform of TRIOBP associated with DFNB28 hearing loss. Amino acids are indicated below
the nucleotide sequences; mutant codons are indicated by red boxes. A, Sequence from a hearing individual from family K who is heterozygous
for 1039CrT (R347X). B, Sequence from a deaf individual from family AK who is homozygous for 1741CrT (Q581X). C, Sequence from a
deaf child who is compound heterozygous for 3055GrA (G1019R) and R347X.
dicted in this region by the iSPOT algorithm (Brannetti
and Helmer-Citterich 2003). Ligand preferences at SH3-
binding sites are determined by motifs that may lie some
distance from a PXXP-containing peptide (Kuriyan and
Cowburn 1997). G1019R lies in a repeated 16-aa motif
that is highly conserved among mammals but does not
appear in any proteins other than TRIOBP.We speculate
that this motif may be involved in determining ligand
preference at this site and that G1019R may disrupt this
role. Future work will test this hypothesis.
We screened the three TRIOBP mutations in 300 un-
related Palestinian hearing controls from different areas
of the West Bank; one individual was heterozygous for
G1019R, and none carried R247X or Q581X. On the
basis of the families reported above, the frequencies of
the three mutant alleles among the 156 probands with
hereditary hearing loss were 0.029 for R247X, 0.032
for Q581X, and 0.003 for G1019R.
The known features of TRIOBP, combined with the
restricted expression of the long isoform, suggest a role
for the long isoform of TRIOBP in hearing loss. The
short isoform of TRIOBP is a widely expressed 67-kDa
protein with an N-terminal pleckstrin homology (PH)
domain and a C-terminal coiled-coil region (ﬁg. 5). Ec-
topically expressed TRIOBP localizes in a periodic fash-
ion to F-actin and enhances cell spreading, and in vitro
binding studies indicate direct interactionbetweenTRIOBP
and F-actin (Seipel et al. 2001). Furthermore, cells with
stably or transiently overexpressed TRIOBP displayed
extensively ﬂattened morphology with enhanced stress
ﬁbers and cortical F-actin. TRIOBP-expressing cellswere
also resistant to the F-actin destabilizer latruniculin B,
which indicates that TRIOBP stabilizes F-actin struc-
tures (Seipel et al. 2001). Unlike other actin-binding pro-
teins, TRIOBP lacks conventional actin-binding do-
mains (Sobue and Sellers 1991). The actin cytoskeleton
is essential for different cellular functions, including cell
shape and movement and membrane trafﬁcking, with
specialized actin architecture in the inner ear. The hear-
ing process and auditory transduction depends on the
development and proper function of hair cells in the
cochlea that contain a group of projections of actin-ﬁlled
stereocilia from their apical cell surfaces (Hudspeth
1997). These stereocilia develop from microvilli on the
apical hair cell surface, in a process that involves elon-
gation and broadening of actin ﬁlaments (Kaltenbach
and Falzarano 1994; Kollmar 1999; Muller and Little-
wood-Evans 2001).
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Figure 4 Proline-rich domain at aa 879–1399 of the long isoform of human TRIOBP that harbors the missense mutation G1019R (G in
bold and inside a box) in a 16-aa conserved repeat (underlined). This region has properties of an SH3-binding domain (Ren et al. 1993); three
PXXP-containing SH3-binding domains (in boxes) are predicted by the iSPOT algorithm (Brannetti and Helmer-Citterich 2003). Ligand pref-
erences at SH3-binding sites are determined by arginine or threonine motifs at some distance from the PXXP peptides (Kuriyan and Cowburn
1997). We speculate that the conserved motifs may be involved in specifying ligand preference and that substitution of arginine for glycine may
disrupt this role. This region is truncated by both nonsense mutations.
Figure 5 Predicted functional domains of the short and long isoforms of TRIOBP
Given the possible role of TRIOBP in actin cytoskel-
etal organization, we examined its localization in the
inner ear—in particular, localization to the actin cyto-
skeleton. Cochlear sensory epithelia, including the or-
gan of Corti, the stria vascularis, and the modiolus, were
dissected from neonatal mice at postnatal days P0–P5.
All procedures involving animals met the guidelines de-
scribed in the National Institutes of Health (NIH) Guide
for the Care and Use of Laboratory Animals and were
approved by the Animal Care and Use Committees of
Tel Aviv University and the University of Washington.
Samples were treated as described elsewhere (Rhodes et
al. 2004).
We performed western analysis of protein frommouse
cochlea, using the monoclonal antibody TARA.27 (kindly
provided by K. Seipel and M. Streuli), which was raised
against aa 13–185 of original TRIOBP, equivalent to aa
1793–2165 of the long isoform. As expected (Seipel et
al. 2001), we detected an isoform of ∼70 kDa (ﬁg. 6A).
We also detected isoforms of ∼150 kDa and 1250 kDa.
The predicted size of the long isoform of TRIOBP in
mouse is 219 kDa. We speculate that the 1250-kDa frag-
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Figure 6 Expression and localization of TRIOBP in mouse cochlea. A, Western blot of two cochlea from newborn (P0) mice hybridized
with monoclonal antibody TARA.27 (Seipel et al. 2001). Bands of ∼70 kDa and ∼50 kDa may represent two isoforms of original TRIOBP
(UCSC Human Genome Browser May 2004 assembly). The band of 1250 kDa (red arrow) may represent posttranslational modiﬁcation of the
predicted 219-kDa novel TRIOBP isoform. The band of ∼150 kDa may represent either a breakdown product of this isoform or an as-yet-
uncharacterized alternatively spliced isoform. B–D, Top view of P0 whole-mount cochleae stained with monoclonal antibody TARA.27 against
TRIOBP (B) and with rhodamine phalloidin, which stains F-actin (C). The protein is detected in the stereocilia of both the outer hair cells
(OHC) and inner hair cells (IHC). Labeling indicates colocalization with actin along the length of the stereocilia and in the microvilli on the
apical portion of the hair cells (D). E–G, Higher magniﬁcation showing stereocilia of outer hair cells. Scale bar is 16 mm in panels B–D and 4
mm in E–G.
ment may correspond to a posttranslationally modiﬁed
product of the 219-kDa isoform and that the ∼150-kDa
fragment may be an as-yet-uncharacterized breakdown
product of this isoform or another alternatively spliced
product.
The TARA.27 antibody revealed expression of TRIOBP
in the sensory epithelium of the inner ear (ﬁg. 6B–6G).
TRIOBP is expressed in both the inner hair cells and
outer hair cells of the organ of Corti. TRIOBP colocal-
izes with the phalloidin-stained F-actin along the length
of the stereocilia and in the microvilli, which are actin-
based projections that precede stereocilia and persist a
few days after birth before being resorbed. Because the
TARA.27 epitope is shared by the short and long
isoforms of TRIOBP, we cannot distinguish relative
amounts of the two isoforms. Localization of these pro-
teins in the cochlear sensory hair cells is consistent with
a role for TRIOBP in the actin cytoskeleton and with
the genetic evidence indicating that the long isoform of
TRIOBP is the gene responsible for DFNB28 hearing
loss.
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Web Resources
Accession numbers and URLs for data presented herein are as
follows:
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for mouse long iso-
form of TRIOBP [accession number DQ278602], human long iso-
form of TRIOBP [accession number DQ278603], and transcripts
from brain [accession number AB051449] and fetal brain [accession
number AK096634])
Hereditary Hearing Loss Homepage, http://webhost.ua.ac.be/hhh/
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UCSC Genome Browser, http://genome.ucsc.edu/
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